Second lectureDr . Guenther Gorka
CEO and Shareholder of DiaSys Diagnostics Systems GmbH Holzheim , Germany
Subject :
– Who is DiaSys
– Metabolic Syndrome and Diabetes  –  short description
– Management of disease : When and how
– Suitable tests
– Focus HbA1c , B-Hydroxybutyrate as metabolic parameters
– Focus Cystatin C as kidney parameter
– The future

Third  lecture : Thursday 6 May 2017
Dr . Tamer Khalil
Business Development Manager EMEA
Subject :
The Role of QFT – Plus in TB elimination .